RIL
VNDA icon

Rothschild Investment LLC’s Vanda Pharmaceuticals VNDA Stock Holding History

Rothschild Investment LLC’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.05K Buy
731
+442
+153% +$3.41K ﹤0.01% 2046
2025
Q4 		$2.55K Buy
289
+94
+48% +$517 ﹤0.01% 2242
2025
Q3 		$973 Sell
195
-55
-22% -$255 ﹤0.01% 2585
2025
Q2 		$1.18K Buy
+250
New +$1.09K ﹤0.01% 2373

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild Investment LLC's VNDA Position: Q1 2026 in Review

Rothschild Investment LLC increased its Vanda Pharmaceuticals (VNDA) stake by 153% in Q1 2026, buying an estimated $3.41K and bringing the position to 731 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

Rothschild Investment LLC first reported a position in VNDA in Q2 2025 and has held it in 4 quarters since. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Rothschild Investment LLC held 731 shares of Vanda Pharmaceuticals worth $5.05K as of Q1 2026.
  • Rothschild Investment LLC bought 442 Vanda Pharmaceuticals shares in Q1 2026, an estimated $3.41K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2046 holding.
  • Rothschild Investment LLC first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.